daprodustat,GSK1278863
daprodustat,GSK1278863 Basic information
- Product Name:
- daprodustat,GSK1278863
- Synonyms:
-
- daprodustat,GSK1278863
- GSK1278863
- Daprodustat
- 2-(1,3-dicyclohexyl-2,4,6-trioxohexahydropyrimidine-5-carboxamido)acetic acid
- N-[(1,3-Dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl]glycine
- GSK1278863; GSK 1278863; GSK-1278863; DAPRODUSTAT
- 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid
- GSK1278863,daprodustat
- CAS:
- 960539-70-2
- MF:
- C19H27N3O6
- MW:
- 393.43
- EINECS:
- 691-659-9
- Product Categories:
-
- API
- Mol File:
- 960539-70-2.mol
daprodustat,GSK1278863 Chemical Properties
- Melting point:
- 237-241oC
- Density
- 1.359±0.06 g/cm3(Predicted)
- storage temp.
- Refrigerator
- solubility
- Chloroform (Slightly), DMSO (Slightly)
- pka
- 3.44±0.10(Predicted)
- form
- Solid
- color
- White to Off-White
daprodustat,GSK1278863 Usage And Synthesis
Uses
Daprodustat is a novel HIF (Hypoxia inducible factor)-prolyl hydroxylase inhibitor.
Biological Activity
daprodustat (gsk1278863) is a hif-prolyl hydroxylase inhibitor.hypoxia stimulates erythropoietin (epo) release through accumulation of hypoxia-inducible factor 1α (hif-1α), resulting in an increase of erythrocyte production by the bone marrow. hif-prolyl hydroxylase inhibitors have been used to selectively activate the phd-signaling pathway, leading to the stabilization of hifα subunits, which can affect the transcription of hif-responsive genes.
in vitro
in-vitro biotransformation data indicated that gsk1278863 was primarily metabolized by cyp2c8 [1].
References
[1] hara k,takahashi n,wakamatsu a,caltabiano s. pharmacokinetics, pharmacodynamics and safety of single, oral doses of gsk1278863, a novel hif-prolyl hydroxylase inhibitor, in healthy japanese and caucasian subjects. drug metab pharmacokinet.2015 dec;30(6):410-8.
[2] brigandi ra,johnson b,oei c,et al. a novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (gsk1278863) for anemia in ckd: a 28-day, phase 2a randomized trial. am j kidney dis.2016 jun;67(6):861-71.
daprodustat,GSK1278863Supplier
- Tel
- 18721429218
- taoyingyu@famobiotech.com
- Tel
- 0086-13852538605 13308012069
- 13308012069@189.cn
- Tel
- 0755-4000505016 13380397412
- 3001272453@qq.com
- Tel
- 0531-67801621 13153106106
- sales@guodingpharma.com
- Tel
- 18616665298
- wenjie.li@bocimed.com
daprodustat,GSK1278863(960539-70-2)Related Product Information
- N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide
- GSK-2126458
- ABT 702 Dihydrochloride
- Danirixin
- GSK1940029
- GSK 189254A
- GSK2110183
- gsk2200150a
- 4-(4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide
- 4-Methoxy-N-(2,4,6-triMethylphenyl)benzenesulfonaMide, 97%